Browsing by Yonsei Author : Chung, Hyun Cheol

Name:
Chung, Hyun Cheol [정현철] http://orcid.org/0000-0002-0920-9471
Department :
College of Medicine (의과대학) - Dept. of Internal Medicine (내과학교실)
Y-HRN :
(Yonsei Health Research Network)
Scopus ID :
(7404006815)

Keyword Cloud

Researcher Network

This table browses all dspace content
Issue DateTitleJournal Title
2020Pembrolizumab After Two or More Lines of Previous Therapy in Patients With Recurrent or Metastatic SCLC: Results From the KEYNOTE-028 and KEYNOTE-158 StudiesJOURNAL OF THORACIC ONCOLOGY
2020Changes in taste and food preferences in breast cancer patients receiving chemotherapy: a pilot studySUPPORTIVE CARE IN CANCER
2020Safety and Efficacy of Durvalumab and Tremelimumab Alone or in Combination in Patients with Advanced Gastric and Gastroesophageal Junction Adenocarcinoma CLINICAL CANCER RESEARCH
2020Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer GASTRIC CANCER
2020Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 StudyJOURNAL OF CLINICAL ONCOLOGY
2020Prognostic role of body composition parameters in gastric/gastroesophageal junction cancer patients from the EXPAND trial JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE
2019Randomised phase II trial comparing four front-line doublets in Asian patients with metastatic gastric cancerEUROPEAN JOURNAL OF CANCER
2019Inhibiting casein kinase 2 overcomes paclitaxel resistance in gastric cancerGASTRIC CANCER
2019S-1 Based Doublet as an Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer: Results from the Randomized Phase III POST Trial CANCER RESEARCH AND TREATMENT
2019Role of probe-based confocal laser endomicroscopy-targeted biopsy in the molecular and histopathological study of gastric cancerJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2019Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma: results from the phase II nonrandomized KEYNOTE-059 study Gastric Cancer
2019Temsirolimus in Asian Metastatic/Recurrent Non-clear Cell Renal Carcinoma CANCER RESEARCH AND TREATMENT
2019Avelumab (anti-PD-L1) as first-line switch-maintenance or second-line therapy in patients with advanced gastric or gastroesophageal junction cancer: phase 1b results from the JAVELIN Solid Tumor trial JOURNAL FOR IMMUNOTHERAPY OF CANCER
2019Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 StudyJOURNAL OF CLINICAL ONCOLOGY
2019Maintenance avelumab versus continuation of first-line chemotherapy in gastric cancer: JAVELIN Gastric 100 study design FUTURE ONCOLOGY
2019Phase II trial of preoperative sequential chemotherapy followed by chemoradiotherapy for high-risk gastric cancerRADIOTHERAPY AND ONCOLOGY
2019A Multicenter Phase II Study of AMG 337 in Patients with MET-Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma and Other MET-Amplified Solid TumorsClinical Cancer Research
2019Landscape of Actionable Genetic Alterations Profiled from 1,071 Tumor Samples in Korean Cancer Patients Cancer Research and Treatment
2019Immunohistochemistry Biomarkers Predict Survival in Stage II/III Gastric Cancer Patients: From a Prospective Clinical Trial Cancer Research and Treatment
2019Differences in the Efficacies of Pazopanib and Gemcitabine/Docetaxel as Second-Line Treatments for Metastatic Soft Tissue SarcomaOncology
2019Behaviors and Attitudes toward the Use of Complementary and Alternative Medicine among Korean Cancer Patients Cancer Research and Treatment
2019Effect of First-line S-1 Plus Oxaliplatin With or Without Ramucirumab Followed by Paclitaxel Plus Ramucirumab on Advanced Gastric Cancer in East Asia: The Phase 2 RAINSTORM Randomized Clinical TrialJAMA Network Open
2019Comprehensive immune profiling and immune-monitoring using body fluid of patients with metastatic gastric cancer Journal for Immunotherapy of Cancer
2019Mesothelin Expression Is a Predictive Factor for Peritoneal Recurrence in Curatively Resected Stage III Gastric CancerONCOLOGIST
2018Identification of Natural Products as Novel PI3KβInhibitors ThroughPharmacophore-based Virtual ScreeningBULLETIN OF THE KOREAN CHEMICAL SOCIETY
2018Efficacy and Safety of Ixabepilone and Capecitabine in Patients With Advanced Triple-negative Breast Cancer: a Pooled Analysis From Two Large Phase III, Randomized Clinical TrialsCLINICAL BREAST CANCER
2018MET in gastric cancer with liver metastasis: The relationship between MET amplification and Met overexpression in primary stomach tumors and liver metastasis.JOURNAL OF SURGICAL ONCOLOGY
2018Ramucirumab Safety in East Asian Patients: A Meta-Analysis of Six Global, Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trials.JOURNAL OF GLOBAL ONCOLOGY
2018Real-Time Tumor Gene Expression Profiling to Direct Gastric Cancer Chemotherapy: Proof-of-Concept "3G" TrialCLINICAL CANCER RESEARCH
2018Prognostic implications of polycomb proteins ezh2, suz12, and eed1 and histone modification by H3K27me3 in sarcoma. BMC CANCER
2018Forty-nine gastric cancer cell lines with integrative genomic profiling for development of c-MET inhibitorINTERNATIONAL JOURNAL OF CANCER
2018Subgroup analysis of East Asian patients in REGARD: A phase III trial of ramucirumab and best supportive care for advanced gastric cancerASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
2018The prognostic value of volume-based parameters using<sup>18</sup>F-FDG PET/CT in gastric cancer according to HER2 statusGASTRIC CANCER
2018Alpha-fetoprotein kinetics in patients with hepatocellular carcinoma receiving ramucirumab or placebo: An analysis of the phase 3 REACH studyBRITISH JOURNAL OF CANCER
2018Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: Pooled analyses after long-term follow-up in KEYNOTE-012BRITISH JOURNAL OF CANCER
2018A Prediction Model of Tumor Progression and Survival in HER2-Positive Metastatic Gastric Cancer Patients Treated with Trastuzumab and ChemotherapyAAPS JOURNAL
2018Marked Loss of Muscle, Visceral Fat, or Subcutaneous Fat After Gastrectomy Predicts Poor Survival in Advanced Gastric Cancer: Single-Center Study from the CLASSIC TrialANNALS OF SURGICAL ONCOLOGY
2018Casein Kinase 2 Inhibitor, CX-4945, as a Potential Targeted Anticancer Agent in Gastric CancerANTICANCER RESEARCH
2018Regulation of proliferation and invasion by the IGF signalling pathway in Epstein-Barr virus-positive gastric cancer JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
2018Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trialLANCET
2018Pembrolizumab in Asia-Pacific patients with advanced head and neck squamous cell carcinoma: Analyses from KEYNOTE-012 CANCER SCIENCE
2017Prevalence and prognostic implications of psychological distress in patients with gastric cancer BMC CANCER
2017A First-Time-in-Human Study of GSK2636771, a Phosphoinositide 3 Kinase Beta-Selective Inhibitor, in Patients with Advanced Solid TumorsCLINICAL CANCER RESEARCH
2017Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 studyLANCET ONCOLOGY
2017Modulation of HAT activity by the BRCA2 N372H variation is a novel mechanism of paclitaxel resistance in breast cancer cell linesBIOCHEMICAL PHARMACOLOGY
2017Complementary utility of targeted next-generation sequencing and immunohistochemistry panels as a screening platform to select targeted therapy for advanced gastric cancer ONCOTARGET
2017Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH studyEUROPEAN JOURNAL OF CANCER
2017Cardiotoxicity of trastuzumab in patients with HER2-positive gastric cancer ONCOTARGET
2017Effects of hormone receptor status on the durable response of trastuzumab-based therapy in metastatic breast cancerBREAST CANCER RESEARCH AND TREATMENT
2017A non-randomized, open-label, single-arm, Phase 2 study of emibetuzumab in Asian patients with MET diagnostic positive, advanced gastric cancer CANCER CHEMOTHERAPY AND PHARMACOLOGY

Browse

Links